Johnson & Johnson (JNJ): FY25 Q2 earnings call, Jul 16, 2025
No Kalshi or Polymarket word markets were listed for Johnson & Johnson’s Jul 16, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
4 matches for “China”; 4 quoted, at least 25 words apart.
…partially offset by competitive pressures in energy and the negative impact of China VBP across the portfolio. In vision contact lenses and other ocular products…
…business declined by 1.6%, driven by competitive pressures, the transformation program and China VBP. Now turning to our consolidated statement of earnings for the second…
…Innovative Medicine as well as med tech macroeconomic factors and VBP in China. Selling, marketing and administrative expenses improved 50 basis points driven by corporate…
…all commercial regions. We also started first cases in new markets like China, which is a major market for us and Australia. And the feedback…
Agents: this page as TSV at /api/v1/appearances/johnson-and-johnson:2025-07-16:earnings_call · words: /api/v1/brief?appearance=johnson-and-johnson:2025-07-16:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP